1. Home
  2. Clinical Topics
  3. FDA approves drug to reduce risk of preterm birth
Clinical TopicsDrugs and DevicesHealthcare & TechnologyNewsWeb ExclusivesWomen's Health

FDA approves drug to reduce risk of preterm birth

Share

The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant women with a history of at least one spontaneous preterm birth. Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts